The Drug Discovery & Development Outlook report provides a comprehensive
overview of the drug development pipeline, highlighting key stages such as target

identification, lead discovery, preclinical research, clinical trials (Phases I, II, III), and
regulatory approval processes. It covers technological innovations such as AI, high-
throughput screening, and CRISPR, which are transforming the drug discovery
process.

The report also analyses trends, along with the challenges of drug development
costs, timeframes, and regulatory hurdles. Additionally, it reviews the competitive
landscape, market drivers, partnerships, and investments that are shaping the
future.